Virtual Medicinal Product (VMP) - Leuprorelin 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes

Navigation

Name Details

Name Start Date End Date
Name Current Name Leuprorelin 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes Start Date 01-12-2024 End Date
Previous Name Previous Name Leuprorelin 3.75mg powder and solvent for suspension for injection pre-filled syringes Start Date 07-07-2011 End Date 30-11-2024
Abbreviated Name Abbreviated Name Leuprorelin 3.75mg inj pre-filled syringes Start Date 07-07-2011

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
pre-filled disposable injection
Unit Dose UOM
pre-filled disposable injection

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous, Intramuscular
Form
Powder and solvent for prolonged-release suspension for inj
Ontology Form/Route
suspensioninjectionprolonged-release.intramuscular, suspensioninjectionprolonged-release.subcutaneous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L02AE02
BNF Start Date End Date
Current BNF 08030402 Start Date 04-04-2022 End Date
Previous BNF 08030402 Start Date 23-05-2012 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
19306211000001104 07-07-2011

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Leuprorelin acetate Based on Ingredient Substance 3.75 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 pre-filled disposable injection 7524 Part VIIIA Category C